These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11156322)

  • 21. Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
    Huang A; Leygue ER; Snell L; Murphy LC; Watson PH
    Am J Pathol; 1997 May; 150(5):1827-33. PubMed ID: 9137105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.
    den Hollander P; Rayala SK; Coverley D; Kumar R
    Cancer Res; 2006 Nov; 66(22):11021-9. PubMed ID: 17108141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
    Kim MS; Lee EJ; Kim HR; Moon A
    Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer.
    Wolf G; Hildenbrand R; Schwar C; Grobholz R; Kaufmann M; Stutte HJ; Strebhardt K; Bleyl U
    Pathol Res Pract; 2000; 196(11):753-9. PubMed ID: 11186170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
    Koo JS; Jung W
    Pathobiology; 2010; 77(6):289-300. PubMed ID: 21266827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway.
    Fenig E; Szyper-Kravitz M; Yerushalmi R; Lahav M; Beery E; Wasserman L; Gutman H; Nordenberg J
    Oncol Rep; 2002; 9(4):875-7. PubMed ID: 12066225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion.
    Qi X; Tang J; Loesch M; Pohl N; Alkan S; Chen G
    Cancer Res; 2006 Aug; 66(15):7540-7. PubMed ID: 16885352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.
    Schneider J; Ruschhaupt M; Buness A; Asslaber M; Regitnig P; Zatloukal K; Schippinger W; Ploner F; Poustka A; Sültmann H
    Int J Cancer; 2006 Dec; 119(12):2974-9. PubMed ID: 17019712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence analysis of the DNA binding domain of the estrogen receptor gene in ER (+)/PR (-) breast cancer.
    Mies C; Voigt W
    Diagn Mol Pathol; 1996 Mar; 5(1):39-44. PubMed ID: 8919544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer.
    Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M
    Breast Cancer Res Treat; 2002 Jan; 71(1):77-83. PubMed ID: 11859876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Frequency of Codon 12 but not Codon 13 and 61 K-ras Gene Mutations in Invasive Ductal Carcinoma of Breast in a South Indian Population.
    Sushma C; Prasad S; Devi R; Murthy S; Rao Ts; Naidu C
    Asian Pac J Cancer Prev; 2015; 16(8):3505-8. PubMed ID: 25921169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese women.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Haruki N; Kobayashi S; Iwase H
    Breast Cancer; 2003; 10(1):70-3. PubMed ID: 12525766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.
    Henrich LM; Smith JA; Kitt D; Errington TM; Nguyen B; Traish AM; Lannigan DA
    Mol Cell Biol; 2003 Sep; 23(17):5979-88. PubMed ID: 12917323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical evalulation of activated Ras and Rac1 as potential downstream effectors of aquaporin-5 in breast cancer in vivo.
    Jensen HH; Login FH; Park JY; Kwon TH; Nejsum LN
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1210-1216. PubMed ID: 28958942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ras activation in human breast cancer.
    von Lintig FC; Dreilinger AD; Varki NM; Wallace AM; Casteel DE; Boss GR
    Breast Cancer Res Treat; 2000 Jul; 62(1):51-62. PubMed ID: 10989985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.
    Conway K; Parrish E; Edmiston SN; Tolbert D; Tse CK; Geradts J; Livasy CA; Singh H; Newman B; Millikan RC
    Breast Cancer Res; 2005; 7(6):R871-80. PubMed ID: 16280033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 gain-of-function mutation in codon 175 is a rare event in human breast cancer.
    Runnebaum IB; Kieback DG; Tong XW; Kreienberg R
    Hum Mol Genet; 1993 Sep; 2(9):1501-2. PubMed ID: 7902164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.